Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England

por Cherla, Avi, Renwick, Matthew, Jha, Ashish, Mossialos, Elias
Publicado 2020

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

por Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S., Gyawali, Bishal, Mossialos, Elias
Publicado 2021

Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014

por Cherla, Avi, Mossialos, Elias, Salcher‐Konrad, Maximilian, Kesselheim, Aaron S., Naci, Huseyin
Publicado 2022

Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England

por Cherla, Avi, Renwick, Matthew, Stefanini, Giulio, Holmes Jr, David R., Mossialos, Elias
Publicado 2020

A Framework for Digital Health Policy: Insights from Virtual Primary Care Systems Across Five Nations

por Srivastava, Divya, Van Kessel, Robin, Delgrange, Marine, Cherla, Avi, Sood, Harpreet, Mossialos, Elias
Publicado 2023